MAPC-GibbsOS: An integrated approach for robust identification of gene regulatory networks

BMC Systems Biology

Volumn 7, Issue SUPPL 5, 2013, Pages

  Shi, Xu ^a   Gu, Jinghua ^a   Chen, Xi ^a   Shajahan, Ayesha ^b   Hilakivi Clarke, Leena ^b   Clarke, Robert ^b   Xuan, Jianhua ^a  

^a State University   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

ARTICLE; BIOLOGY; BREAST TUMOR; CLUSTER ANALYSIS; DNA MICROARRAY; GENE REGULATORY NETWORK; GENETICS; GENOMICS; HUMAN; LABORATORY DIAGNOSIS; METABOLISM; METHODOLOGY;

BREAST NEOPLASMS; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; FALSE POSITIVE REACTIONS; GENE REGULATORY NETWORKS; GENOMICS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRANSCRIPTION FACTORS;

EID: 84889690492     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-7-S5-S4     Document Type: Article

References (26)

1. Vaquerizas JM, Kummerfeld SK, Teichmann SA, Luscombe NM. A census of human transcription factors: function, expression and evolution. Nature Review Genetics 2009, 10:252-263.
2. Gong T, Xuan J, Chen L, Riggins RB, Li H, Hoffman EP, Clarke R, Wang Y. Motif-guided sparse decomposition of gene expression data for ergulatory module identification. BMC Bioinformatics 2011, 12:82. 10.1186/1471-2105-12-82, 3072956, 21426557.
3. Yeung KY, Ruzzo WL. Principal component analysis for clustering gene expression data. Bioinformatics 2001, 17:763-774. 10.1093/bioinformatics/17.9.763, 11590094.
4. Lee S, Batzoglou S. Application of independent component analysis to microarrays. Genome Biology 2003, 4:R76. 10.1186/gb-2003-4-11-r76, 329130, 14611662.
5. Dembele D, Kastner P. Fuzzy c-means method for clustering microarray data. Bioinformatics 2003, 19:973-980. 10.1093/bioinformatics/btg119, 12761060.
6. Latchman DS. Transcription factors as potential targets for therapeutic drugs. Current Pharmaceutical Biotechnology 2000, 1:57. 10.2174/1389201003379022, 11467361.
7. Sabatti C, James GM. Bayesian sparse hidden components analysis for transcription regulation networks. Bioinformatics 2006, 22:739-746. 10.1093/bioinformatics/btk017, 16368767.
8. Liao JC, Boscolo R, Yang Y-L, Tran LM, Sabatti C, Roychowdhury VP. Network component analysis: reconstruction of regulatory signals in biological systems. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:15522-15527. 10.1073/pnas.2136632100, 307600, 14673099.
9. Chang C, Ding Z, Hung YS, Fung PCW. Fast network component analysis (FastNCA) for gene regulatory network reconstruction form microarray data. Bioinfomatics 2008, 24:1349-1358.
10. Gu J, Xuan J, Riggins RB, Chen L, Wang Y, Clarke R. Robust identification of transcriptional regulatory networks using a Gibbs sampler on outlier sum statistic. Bioinformatics 2012, 28:1990-1997. 10.1093/bioinformatics/bts296, 3400952, 22595208.
11. Tibshirani R, Hastie T. Outlier sums for differential gene expression analysis. Biostatistics 2006, 8:2-8.
12. Casella G, George EI. Explaining the Gibbs sampler. American Statistician 1992, 46:167-174.
13. Frey BJ, Dueck D. Clustering by passing messages between data points. Science 2007, 315:972-976. 10.1126/science.1136800, 17218491.
14. Hubert L, Arabie P. Comparing partitions. Journal of Classification 1985, 2:193-218.
15. Symmans WF, Hatzis C, Sotiriou C, Andre F, Peintinger F, Regitnig P, Daxenbichler G, Desmedt C, Domont J, Marth C, Delaloge S, Bauernhofer T, Valero V, Booser DJ, Hortobagyi GN, Pusztai L. Genomic index of sensitivity to endocrine therapy for breast cancer. J Clin Oncol 2010, 28:4111-9. 10.1200/JCO.2010.28.4273, 2953969, 20697068.
16. Loi S, Haibe-Kains B, Desmedt C, Wirapati P, Lallemand F, Tutt AM, Gillet C, Ellis P, Ryder K, Reid JF, Daidon MG, Pierotti MA, Berns EM, Jansen MP, Foekens JA, Delorenzi M, Bontempi G, Piccart MJ, Sotiriou C. Predicting prognosis using molecular profiling in estrogen receptor positive breast cancer treated with tamoxifen. BMC Genomics 2008, 9:239. 10.1186/1471-2164-9-239, 2423197, 18498629.
17. Bjomstrom L, Sjoberg M. Mechanisms of estrogen receptor signaling: convergenece of genomic and nongenomic actions on target genes. Molecular Endocrinology 2005, 19:833-842. 10.1210/me.2004-0486, 15695368.
18. Mishra GR, Suresh M, et al. Human protein reference database--2006 update. Nucleic Acids Res 2006, 34:D411-414. 10.1093/nar/gkj141, 1347503, 16381900.
19. Orton RJ, Sturm OE, Vyshemirsky V, Calder M, Gilbert DR, Kolch W. Computational modelling of the receptor-tyrosine-kinase-activated MAPK pathway. Biochemical Journal 2005, 392:249-261. 10.1042/BJ20050908, 1316260, 16293107.
20. Daschner PJ, Ciolino HP, Plouzek CA, Yeh GC. Increased AP-1 activiety in drug resisitant human breast cancer MCF-7 cells. Breast Cancer Research and Treatment 1999, 53:229-240. 10.1023/A:1006138803392, 10369069.
21. Xiao X, Li BX, Mitton B, Ikeda A, Sakamoto KM. Targeting CREB for cancer therapy: friend or foe. Current cancer drug targets 2010, 10:384-391. 10.2174/156800910791208535, 20370681.
22. Sankpal NV, Moskaluk CA, Hampton GM, Powell SM. Overexpression of CEBPβ correlates with decreased TFF1 in gastric cancer. Oncogene 2006, 25:643-649.
23. Boudny V, Kovarik J. JAK/STAT signaling pathways and cancer. Janus kinases/signal transducers and activators of transcription. Neoplasma 2002, 49:349-355.
24. Kakizawa T, et al. Silencing mediator for retinoid and thyroid hormone receptors interact with octamer transcription factor-1 and acts as a transcritpinal repressor. Journal of Biological Chemistry 2001, 276:9720-9725. 10.1074/jbc.M008531200, 11134019.
25. Li L, Davie JR. The role of Sp1 and Sp3 in normal and cancer cell biology. Annals of Anatomy 2010, 192:275-283. 10.1016/j.aanat.2010.07.010, 20810260.
26. Buggy Y, Maguire TM, McGreal G, McDermott E, Hill ADK, O'Higgins N, Duffy MJ. Overexpression of the Ets-1 trancription factor in human breast cancer. British Journal of Cancer 2004, 91:1308-1315. 10.1038/sj.bjc.6602128, 2409905, 15365563.